English | Español
Patient Daily | Feb 4, 2026

Study links eating foods high in melatonin to reduced rates of obesity and depression
Patient Daily | Feb 4, 2026

Lifetime heavy drinking increases colorectal cancer risk according to new US study
Patient Daily | Feb 4, 2026

Exploring targeted protein degradation as an emerging tool against antimicrobial resistance
Patient Daily | Feb 4, 2026

Alzheimer Europe projects sharp rise in number of Europeans living with dementia by 2050
Patient Daily | Feb 4, 2026

UVA Health team develops rapid low-cost vaccine platform targeting global outbreaks
Patient Daily | Feb 4, 2026

Four-biomarker blood test shows promise for earlier detection of pancreatic cancer
Patient Daily | Feb 4, 2026

Study maps separate impacts of genetics and environment on human immune system
Patient Daily | Feb 4, 2026

Researchers report success using fecal transplants to aid immunotherapy response in some cancers

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'